← All indications
End Stage Liver Disease
Final stage of a liver disease when the liver failure is irreversible and LIVER TRANSPLANTATION is needed.
Drugs by status
Phase 4 trials (12)
Phase 2 trials (5)
Phase 1 trials (6)
Organizations
Organization Involved with Phase 4 Indications (25)
- Baylor University
- Harvard University
- Emory University
- Govind Ballabh Pant Institute of Postgraduate Medical Education and Research
- King Faisal University
- New York University
- Northwestern University
- Oregon Health and Science University
- Postgraduate Institute of Medical Education and Research
- Tufts University
- University of Medicine and Dentistry of New Jersey
- University of Southern California
- University of Virginia
- Yonsei University
- Mayo Clinic
- University of California, Los Angeles
- University of California, San Francisco
- University of Chicago
- University of Cincinnati
- University of Naples Frederico II
- Medical University of South Carolina
- University of Alabama, Birmingham
- University of Texas, San Antonio
- New York Presbyterian Hospital
- CEINGE - Biotecnologie Avanzate, Napoli, Italia
Organization Involved with Phase 3 Indications (12)
- Grifols
- Changi General Hospital
- Singapore General Hospital
- University of Groningen
- University of Regensburg
- Institute of Liver and Biliary Sciences, India
- Leiden University
- Asian Institute of Gastroenterology
- National University of Singapore
- Erasmus University Rotterdam
- Nanyang Technological University
- Dr. F. Köhler Chemie GmbH
Organization Involved with Phase 2 Indications (17)
- Merck
- Cubist
- FGK Clinical Research GmbH
- Rheacell GmbH & Co. KG
- Promethera Biosciences
- French National Agency for Research on AIDS and Viral Hepatitis
- University of London
- King Saud University
- Nanjing Medical University
- University of Heidelberg
- Tianjin University of Traditional Chinese Medicine
- Sun Yat-Sen University
- Metropolitan Liver Diseases/ Gastroenterology Center
- TICEBA GmbH
- IQVIA
- Tianjin Weikai Bioeng., Ltd.
- Akaza Bioscience Ltd
Organization Involved with Phase 1 Indications (14)
Organization Involved with Other Experimental Indications (26)
- Huazhong University of Science and Technology
- Guangxi Medical University
- Jilin University
- Shanghai University of Traditional Chinese Medicine
- Shenzhen Third People's Hospital
- University of Rochester
- University of Zurich
- University of Leipzig
- Capital Medical University
- Fudan University
- Hunan University of Traditional Chinese Medicine
- Xiamen University
- University of Colorado, Denver
- Southern Medical University
- Government of China
- Henan Medical University
- Hepatobiliary Disease Hospital of Jilin Province, Jilin, China
- University of Sao Paulo
- Shenzhen University
- American College of Gastroenterology
- Ghent University
- China Medical University
- People's Liberation Army of China
- Hubei University of Chinese Medicine
- Fuzhou Infectious Hospital
- Hangzhou Xixi hospital